JCI-accredited · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Conditions & Outlook

Lung Transplant Waiting List: Procedure, Recovery and Results

10 min read Published August 15, 2026
Patient waiting in hospital corridor with medical staff nearby.
Quick answer

Lung transplant listing is considered for selected people with severe lung disease when other treatments are no longer sufficient. Waiting time varies widely and depends on medical urgency, blood type, body size, antibody status and donor availability.

Key Takeaways

  • Lung transplant listing is considered for selected people with severe lung disease when other treatments are no longer sufficient.
  • Waiting time varies widely and depends on medical urgency, blood type, body size, antibody status and donor availability.
  • Transplant surgery may involve one or both lungs and is followed by intensive monitoring, rehabilitation and lifelong anti-rejection medicines.
  • The main long-term challenge after lung transplantation is preventing and managing rejection and infection while preserving lung function.
  • Regular follow-up, medication adherence, exercise and infection-prevention measures are central to recovery and long-term health.

A lung transplant waiting list is a carefully managed process that matches people with advanced lung disease to suitable donor lungs. Eligibility, waiting time, surgery, recovery and long-term results depend on the underlying condition, overall health, donor availability and ongoing follow-up care.

Overview: What Is a Lung Transplant Waiting List?

A lung transplant waiting list is a national or regional allocation system used to match eligible people with donated lungs. It is not simply a first-come, first-served queue. Transplant teams assess medical need and the likelihood that a person can benefit from surgery, then matching systems consider donor and recipient compatibility when lungs become available.

People are usually assessed for listing when they have advanced lung disease that remains severe despite appropriate treatment. A transplant may be considered for conditions such as advanced chronic obstructive pulmonary disease, pulmonary fibrosis, cystic fibrosis, pulmonary hypertension and some forms of bronchiectasis. The aim is to improve survival and day-to-day function when the expected benefit outweighs the risks.

Being placed on a lung transplant waiting list means the person must remain ready for a possible call at any time. The transplant team continues to monitor health, update test results and provide treatment while the person waits. If health changes substantially, the team may adjust the care plan or reassess listing status.

How Candidacy and Donor Matching Work

How Candidacy and Donor Matching Work — lung transplant waiting list

A specialist transplant team performs a detailed assessment before listing someone for a lung transplant. This commonly includes lung-function testing, imaging, heart evaluation, blood tests, infection screening, nutritional assessment, rehabilitation assessment and discussions about mental health and practical support. The process helps identify whether surgery and lifelong follow-up can be undertaken as safely as possible.

Eligibility depends on more than the severity of lung disease. Teams consider whether other organs, especially the heart and kidneys, can support transplantation; whether active infection or cancer is present; and whether the person can take medicines reliably and attend frequent appointments. Smoking and nicotine use must be stopped, and substance-use concerns need appropriate treatment before transplantation can be considered.

When a donor organ becomes available, matching considers blood group, lung size, medical urgency, geographical logistics and immune compatibility. Some people have antibodies that make matching more complex. A suitable offer may not be accepted if the donor lungs or the recipient’s current health make the expected risk too high.

  • Single-lung transplantation replaces one lung and may be suitable for selected conditions.
  • Double-lung transplantation replaces both lungs and is common for diseases affecting both lungs or with chronic airway infection.
  • In uncommon situations, a heart-lung transplant may be considered when both organs are severely affected.

What Is the Average Time Someone Is on the Lung Transplant Waiting List?

What Is the Average Time Someone Is on the Lung Transplant Waiting List? — lung transplant waiting list

There is no reliable single average time on a lung transplant waiting list. Some people receive an offer within days or weeks, while others wait many months or longer. Waiting time changes over time and differs between countries, transplant programs and donor-allocation systems.

The time depends on factors such as blood type, body size, donor availability, disease severity, location, immune antibodies and whether one or two lungs are needed. A person whose condition worsens may receive a different priority according to the allocation rules used by their transplant network, but urgency alone does not guarantee a rapid match.

While waiting, patients should attend all scheduled reviews and promptly report hospital admissions, new infections, changes in weight, worsening breathlessness or new heart symptoms. The team may recommend pulmonary rehabilitation, oxygen therapy, nutrition support, vaccines and treatment adjustments to help maintain the best possible condition for surgery.

Lung Transplant Procedure: Step by Step

When suitable donor lungs are identified, the transplant team contacts the patient and asks them to come to the hospital without delay. On arrival, clinicians repeat key checks to confirm that transplantation remains appropriate. The donor lungs are also assessed carefully before the operation proceeds.

The operation is performed under general anaesthesia. The surgeon removes the diseased lung or lungs and connects the donor lung airways and blood vessels. A heart-lung machine or other temporary circulation support may be used in some operations, particularly when replacing both lungs or when the heart needs additional support.

After surgery, the patient is cared for in an intensive care unit. A breathing tube and ventilator are commonly needed initially, followed by gradual reduction of breathing support as the new lungs begin to function. Chest drains, intravenous medicines and close monitoring are used to detect bleeding, fluid changes, infection or early rejection.

Transplantation is one part of a longer treatment pathway. For people exploring surgical options for end-stage lung disease, lung transplant treatment should be discussed with a qualified transplant team, who can explain local eligibility criteria and care arrangements.

How Difficult Is Recovery From a Lung Transplant?

Recovery from a lung transplant is significant and requires time, structured rehabilitation and lifelong medical follow-up. The early hospital stay may last several weeks, although this varies considerably. Recovery can be longer if complications occur, if breathing support is needed for longer than expected or if strength and nutrition have declined before surgery.

In the first days and weeks, the focus is on breathing independently, pain control, walking, airway clearance, nutrition and learning how to take anti-rejection medicines. Physiotherapists guide gradual activity and breathing exercises. Many people notice that breathing can improve substantially once they recover from the operation, but stamina and muscle strength build progressively rather than immediately.

After discharge, frequent blood tests, clinic visits, imaging and lung-function checks are needed. Some programs use bronchoscopy at planned intervals to inspect the airways and obtain samples for signs of infection or rejection. Patients must take immunosuppressive medicines exactly as prescribed and should never stop or change them without advice from their transplant team.

Emotional adjustment is also an important part of recovery. It is common to experience uncertainty, low mood, sleep difficulties or stress during a long period of illness and treatment. Support from family, rehabilitation staff, mental health professionals and transplant peer-support services can be helpful.

Benefits, Risks and the Biggest Problem With Lung Transplants

For appropriately selected patients, a lung transplant can reduce severe breathlessness, improve exercise capacity and support a more active daily life. It may also extend life for people with progressive lung disease who have limited alternatives. Results vary with the underlying disease, age, general health, surgical course and long-term response to treatment.

The biggest long-term problem with lung transplants is the balance between rejection and infection. The immune system recognizes the transplanted lung as foreign, so recipients need lifelong medicines to suppress immune activity. These medicines lower rejection risk but also increase susceptibility to infections and can contribute to side effects such as high blood pressure, kidney problems, diabetes, bone thinning and some cancers.

Rejection can be acute, occurring relatively early after surgery, or chronic, developing gradually over time. Chronic lung allograft dysfunction is a major cause of reduced transplant function in the longer term. Regular surveillance can identify changes before symptoms become severe, but no follow-up approach can remove all risk.

Other potential complications include bleeding, blood clots, airway healing problems, fluid accumulation, irregular heart rhythms and medication interactions. Transplant teams explain these risks in relation to the individual, helping patients make an informed decision before joining the waiting list.

What Are the Odds of Surviving a Lung Transplant?

Survival after lung transplantation has improved with advances in surgery, donor management, infection prevention and anti-rejection treatment. However, it remains a major operation with meaningful short- and long-term risks. A person’s outlook cannot be predicted from a general survival figure alone.

Outcome is influenced by the reason for transplantation, how ill the person is at surgery, age, other medical conditions, donor-organ quality, complications after surgery and the ability to maintain lifelong treatment and follow-up. The transplant team can provide the most relevant information using current outcomes from the program and the person’s own clinical profile.

Long-term success also involves protecting the transplanted lungs. This includes taking medicines consistently, attending surveillance appointments, avoiding tobacco and second-hand smoke, following food-safety guidance, keeping recommended vaccinations up to date and seeking early advice for fever, worsening cough or shortness of breath.

Patients may find it helpful to ask their team about expected recovery milestones, likely rehabilitation needs, possible complications and the support available to family members. Clear planning does not eliminate uncertainty, but it can make the transplant journey more manageable.

When to Seek Medical Care

Anyone on a lung transplant waiting list should contact their transplant coordinator or clinical team promptly for fever, chills, a new or worsening cough, increased mucus, chest pain, fainting, swelling, a marked fall in exercise ability or worsening shortness of breath. These symptoms may have many causes, but infections and changes in heart or lung function need early assessment in people with advanced lung disease.

Emergency care is appropriate for severe breathing difficulty, blue or grey lips, confusion, coughing up a significant amount of blood, severe chest pain or loss of consciousness. A person who receives a potential donor call should follow the transplant center’s instructions and avoid eating or drinking if told to do so.

After transplantation, new breathlessness, fever, reduced home spirometry readings where used, persistent vomiting, inability to take medicines or concerns about wound healing should be reported urgently. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals support diagnosis and treatment for international patients who need coordinated transplant-related assessment and care.

Frequently asked questions

What is a lung transplant waiting list?

A lung transplant waiting list is a system that identifies eligible patients and matches them with suitable donated lungs. Allocation is based on clinical factors and compatibility, not only on how long someone has waited. The exact process differs by country and transplant program.

Can someone be removed from the lung transplant waiting list?

Yes. A transplant team may temporarily make a person inactive or remove them from the list if they develop an infection, another serious illness or a condition that makes surgery unsafe. This decision may be reviewed if the issue improves or can be treated.

What is the average time someone is on the lung transplant waiting list?

Waiting time varies greatly, from a short period to many months or longer. Blood type, body size, donor availability, immune compatibility, urgency and local allocation policies all affect timing. The transplant coordinator can explain the factors most relevant to an individual patient.

How difficult is recovery from a lung transplant?

Recovery is demanding because it involves major surgery, intensive monitoring, rehabilitation and lifelong medication. Most patients need weeks of hospital and home recovery, followed by frequent appointments. Progress differs between individuals, particularly when complications occur.

What are the odds of surviving a lung transplant?

Lung transplantation can provide meaningful survival and quality-of-life benefits for selected patients, but it carries substantial risks. Individual outcomes depend on the lung condition, overall health, operation, donor factors and long-term complications. A transplant center can discuss current program data and personalized expectations.

What is the biggest problem with lung transplants?

The central long-term challenge is preventing rejection without suppressing the immune system so much that serious infections and medication side effects occur. Chronic rejection-related loss of lung function is also a major concern. Lifelong monitoring and consistent use of anti-rejection medicine are essential.

References

  • International Society for Heart and Lung Transplantation
  • NHS Blood and Transplant
  • United Network for Organ Sharing
  • European Respiratory Society
  • National Heart, Lung, and Blood Institute

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.

Add Acıbadem on Google

Add us as a Preferred Source to see more of our trusted health content across Google Search, AI Overviews and Discover.

Share this page
Was this content helpful?
Your feedback helps us improve.
Dr. Mohamed Al-Qadi
Dr. Mohamed Al-Qadi, MD
Author
View profile →
Keep Reading

More from the Health Library

Specialists

Related Specialists

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.